Radiotherapy and Concomitant Intra-Arterial Docetaxel Combined With Systemic 5-Fluorouracil and Cisplatin for Oropharyngeal Cancer: A Preliminary Report-Improvement of Locoregional Control of Oropharyngeal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 2, 2009, Pages 338-342

  Oikawa, Hirobumi ^a   Nakamura, Ryuji ^a   Nakasato, Tatsuhiko ^a   Nishimura, Kohji ^a   Sato, Hiroaki ^a   Ehara, Shigeru ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

chemotherapy; docetaxel; intra arterial infusion; Oropharyngeal cancer; radiotherapy

Indexed keywords

5-FLUOROURACIL; ACUTE TOXICITY; CANCER PROGRESSION; CAROTID ARTERY; CHEMORADIOTHERAPY; CHEMOTHERAPY AGENTS; CIS-PLATIN; DOCETAXEL; EXTERNAL BEAM RADIOTHERAPY; INTRA-ARTERIAL INFUSION; LOCOREGIONAL CONTROL; LOCOREGIONAL CONTROL RATE; LYMPH NODE; METASTATIC LYMPH NODES; MUCOSITIS; OROPHARYNGEAL CANCER; OVERALL SURVIVAL RATES; PARTIAL RESPONSE; PRIMARY RESPONSE; TUMOR BED; TUMOR RESPONSE;

BODY FLUIDS; CHEMOTHERAPY; OPTICAL SENSORS; PLATINUM COMPOUNDS; RADIOTHERAPY; TOXICITY;

TUMORS;

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMORADIOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUKOPENIA; MALE; MIDDLE AGED; MUCOSITIS; OROPHARYNGEAL NEOPLASMS; RADIODERMATITIS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; TAXOIDS;

EID: 69549084705     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.084     Document Type: Article

References (14)

1. Merlano M., Benasso M., Corvo R., et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88 (1996) 583-589
2. Marcial V.A., Pajak T., Mohiuddin M., et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 66 (1990) 1861-1868
3. Vokes E.E., and Weichselbaum R.R. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8 (1990) 911-934
4. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
5. Rabbani A., Hinerman R.W., Schmalfuss I.M., et al. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol 30 (2007) 283-286
6. Robbins K.T., Kumar P., Wong F.S.H., et al. Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients. Head and Neck 22 (2000) 687-693
7. Calais G., Bardet E., Sire C., et al. Radiotherapy with concomitant weekly docetaxel for stage III/IV oropharynx carcinoma: Results of the 98-02 GORTEC phase II trial. Int J Radiat Oncol Biol Phys 58 (2004) 161-166
8. Vermorken J.B., Remenar E., Herpen C.V., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 (2007) 1695-1704
9. Posner M.R., Glisson B., Frenette G., et al. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol 19 (2001) 1096-1104
10. Haddad R., Tishiler R.B., Norris C.M., et al. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. Oncologist 8 (2003) 35-44
11. Haddad R., Colevas A.D., Tishler R., et al. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck. Cancer 97 (2003) 412-418
12. Akisada T., Harada T., Takemoto T., et al. A case of advanced hypopharyngeal carcinoma successfully treated with superselective intra-arterial infusion of docetaxel. Jpn J Cancer Chemother 29 (2002) 323-328
13. Robbins K.T., Doweck I., Samant S., et al. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT). Laryngoscope 114 (2004) 411-417
14. Machtay M., Moughan J., Trotti A., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol 26 (2008) 3582-3589